$0.58
+0.02 (+3.47%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+384.4% upside
Low Target
$1.78
Average Target
$2.82
High Target
$3.37
Current Price
$0.58
Current
$0.58
$0.58
Target
$2.82
$2.82
$1.78
$2.82 avg
$3.37
Scenario Analysis
Bear Case
$1.78
205.7%
Low target
Base Case
$2.82
+384.4%
Avg target
Bull Case
$3.37
+478.8%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$2.24
-74.0% from high
52-Week Low
$0.54
+7.8% from low
Target vs 52W High
$2.82
+26.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |